Financhill
Sell
21

CRSP Quote, Financials, Valuation and Earnings

Last price:
$36.14
Seasonality move :
22.33%
Day range:
$33.50 - $34.64
52-week range:
$30.04 - $67.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.52x
Volume:
3.1M
Avg. volume:
2.3M
1-year change:
-38.32%
Market cap:
$2.9B
Revenue:
$35M
EPS (TTM):
-$4.37

CRSP Analysts' Consensus Rating

The 23 analysts providing 12-month price projections for CRISPR Therapeutics AG shares anticipate an average target of $81.00, ranging from a low estimate of $32.00 to a high estimate of $268.00. This average target implies a growth of 136.5% compared to the current stock price of $34.25.

Consensus Price Target

$81.00

Highest Price Target

$268.00

Lowest Price Target

$32.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 11 12 12

Hold 11 10 10

Sell 2 1 1
Consensus Leans Bullish Buy Buy

CRSP Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.

Buy
92
TPB alert for May 8

Turning Point Brands [TPB] is down 6.67% over the past day.

Buy
74
LIVN alert for May 8

LivaNova PLC [LIVN] is up 1.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock